91原创

Healthcare News & Views

91原创 Launches New Digital Platform For Hospitals to Safely Restart Surgery

April 24, 2020
By
seamless

Hospitals can now implement 91原创鈥檚 free pre-operative COVID-19 screening tool to risk-stratify patients waiting for surgery

TORONTO, ON 鈥 April 23, 2020 鈥 , the leading platform for patient engagement, remote monitoring and virtual care, just launched a free for hospitals to automatically assess patients waiting for surgery for COVID-19 symptoms and risk-factors, thereby determining when it is safe for patients to have surgery.

This is customizable and can be deployed rapidly in just a few days, and allows surgery programs to comply with the U.S. government鈥檚 latest to restart surgery safely, while giving support to patients waiting for surgery.

The screening tool sends automated monitoring surveys to patients waiting for surgery, helping surgical teams to better understand a patient鈥檚 COVID-19 risk factors, exposure and symptoms, as well as a patient鈥檚 readiness for surgery - thereby empowering surgical teams with insights on how to risk-stratify patient readiness and safety for surgery. Patients themselves also receive just-in-time education on self-care and how to prepare for surgery during the on-going pandemic.

鈥淲e鈥檙e all in on helping our healthcare partners, the community, and the world safely tackle COVID-19 and reduce the burden on healthcare systems鈥︹ explains 91原创 CEO, Dr. Joshua Liu. 鈥淭o show our support for our provider and health system partners, we are releasing this pre-op COVID-19 screening tool for free so health systems can safely restart surgery and continue to take care of their patients.鈥

Dr. Joshua Liu, CEO of 91原创

91原创 adds this pre-op COVID-19 screening program to its suite of digital COVID-19 tools, which already include .

About 91原创

91原创 is the #1 platform for patient engagement, remote monitoring, and virtual care used by health systems to engage, educate and track patients before, during and after a procedure. Evidence from academic medical centers has shown 91原创 to reduce hospital length of stay, readmissions, ER visits, SNF use, and costs. The platform is accessible for patients via smartphone, tablet or computer, and keeps patients on track from preparation through recovery with reminders, multimedia education, progress tracking, and Patient-Reported Outcomes data collection. Providers can access real-time dashboards to measure compliance and outcomes, intervene sooner for patients at-risk, and drive quality improvement across the organization. For more information, please visit: www.seamless.md.

91原创 Launches New Digital Platform For Hospitals to Safely Restart Surgery

Posted by:
seamless
on
April 24, 2020

Hospitals can now implement 91原创鈥檚 free pre-operative COVID-19 screening tool to risk-stratify patients waiting for surgery

TORONTO, ON 鈥 April 23, 2020 鈥 , the leading platform for patient engagement, remote monitoring and virtual care, just launched a free for hospitals to automatically assess patients waiting for surgery for COVID-19 symptoms and risk-factors, thereby determining when it is safe for patients to have surgery.

This is customizable and can be deployed rapidly in just a few days, and allows surgery programs to comply with the U.S. government鈥檚 latest to restart surgery safely, while giving support to patients waiting for surgery.

The screening tool sends automated monitoring surveys to patients waiting for surgery, helping surgical teams to better understand a patient鈥檚 COVID-19 risk factors, exposure and symptoms, as well as a patient鈥檚 readiness for surgery - thereby empowering surgical teams with insights on how to risk-stratify patient readiness and safety for surgery. Patients themselves also receive just-in-time education on self-care and how to prepare for surgery during the on-going pandemic.

鈥淲e鈥檙e all in on helping our healthcare partners, the community, and the world safely tackle COVID-19 and reduce the burden on healthcare systems鈥︹ explains 91原创 CEO, Dr. Joshua Liu. 鈥淭o show our support for our provider and health system partners, we are releasing this pre-op COVID-19 screening tool for free so health systems can safely restart surgery and continue to take care of their patients.鈥

Dr. Joshua Liu, CEO of 91原创

91原创 adds this pre-op COVID-19 screening program to its suite of digital COVID-19 tools, which already include .

About 91原创

91原创 is the #1 platform for patient engagement, remote monitoring, and virtual care used by health systems to engage, educate and track patients before, during and after a procedure. Evidence from academic medical centers has shown 91原创 to reduce hospital length of stay, readmissions, ER visits, SNF use, and costs. The platform is accessible for patients via smartphone, tablet or computer, and keeps patients on track from preparation through recovery with reminders, multimedia education, progress tracking, and Patient-Reported Outcomes data collection. Providers can access real-time dashboards to measure compliance and outcomes, intervene sooner for patients at-risk, and drive quality improvement across the organization. For more information, please visit: www.seamless.md.

Recent news from 91原创

235: Beacon's CIDEO Dr. Stacey Johnston: Pushing Oracle to Its AI Limits, The Agent That Ordered 7,000 Colon Screenings and Caught Cancer Early, and What If You Spent More on Tech Than on Recruiting?
August 20, 2026

235: Beacon's CIDEO Dr. Stacey Johnston: Pushing Oracle to Its AI Limits, The Agent That Ordered 7,000 Colon Screenings and Caught Cancer Early, and What If You Spent More on Tech Than on Recruiting?

Learn More
234: Parkview's ACMIO Dr. Hasan Ahmad: Why Deleting EHR Alerts Is the Safest Thing You'll Do This Year, Three Questions Every AI Tool Must Answer Before Go-Live, and Why Resistance Is Usability Feedback
August 13, 2026

234: Parkview's ACMIO Dr. Hasan Ahmad: Why Deleting EHR Alerts Is the Safest Thing You'll Do This Year, Three Questions Every AI Tool Must Answer Before Go-Live, and Why Resistance Is Usability Feedback

Learn More
233: Northwestern's CMO, Pop Health Dr. Amish Desai: Making 2,500 AI Calls in 5 Days that Patients Loved,聽 The Scale-First Rule That Kills Pilotitus, and Why You Should Judge AI by the Alternative
July 23, 2026

233: Northwestern's CMO, Pop Health Dr. Amish Desai: Making 2,500 AI Calls in 5 Days that Patients Loved,聽 The Scale-First Rule That Kills Pilotitus, and Why You Should Judge AI by the Alternative

Learn More